RT Journal Article
SR Electronic
T1 Analysis of Burkina Faso’s institutional framework and budget allocations for NCDs control and monitoring
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.10.29.24316362
DO 10.1101/2024.10.29.24316362
A1 Ouedraogo, Moussa
A1 Sanou, Dia
A1 Goubgou, Mahamadé
A1 Bambara, Estelle Aissa
A1 Tirogo, Souleymane
A1 Savadogo, Aly
YR 2024
UL http://medrxiv.org/content/early/2024/10/30/2024.10.29.24316362.abstract
AB Diet-related non-communicable diseases (NCDs) are today a major public health problem and a global development challenge. Yet governance responses to these diseases are still in their infancy in most low-income countries like Burkina Faso. How Burkina Faso organizes itself institutionally and financially to respond adequately to NCDs is unknown to the scientific community. The aim was to analyze Burkina Faso’s institutional framework and budget allocations. This was a cross-sectional survey based on mixed (qualitative and quantitative) data collection. The analysis revealed a number of difficulties in the institutional framework hindering the performance of the fight against NCDs in Burkina Faso, including (i) the absence of a multi-sectoral policy or strategic plan involving all stakeholders, (ii) the absence of a multi-sectoral coordinating body and (iii) the lack of sufficient financial resources. A total of twentynine (29) budget lines related to the prevention and/or management of NCDs were identified, with a total budget of 17.33 billion FCFA ($29.8 million), or an average of $2.72 million per year. This represents only 1.55% of the total budget of the Ministry of Health over the same period. We recommend, among other things, the development of a national multi-sectoral policy with a clear definition of the roles and responsibilities of each player, the creation of a coordinating body, improved funding, and greater attention to NCDs in the provision of primary healthcare services.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo specific funding support was received for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol was approved by the Ethics Committee for Health Research based in Ouagadougou, Burkina Faso.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Not ApplicableNo restriction